DOI: 10.32098/mltj.04.2019.15

Short-Term Efficacy and Safety of Betamethasone Valerate 2.25 mg Medicated Plaster in Patients with Chronic Lateral Epicondylitis: Results of a Randomised, Double Blind, Placebo-controlled Study

Authors

  • S. Bernasconi Unit of Orthopaedics and Traumatology, General Hospital, Legnano (MI), Italy
  • A. Causero Clinic of Orthopedics, Academic Hospital of Udine, Udine, Italy
  • G. Giaffreda Operative Unit of Orthopaedy and Traumatology, Hospital of Rho (MI), Italy
  • R. Papalia Department of Orthopaedic and Trauma Surgery, University Campus Bio-Medico of Rome, Rome, Italy
  • G. Caruso Unit of Orthopaedic and Traumatology, University of Ferrara, Ferrara, Italy
  • G. Bonanno Operative Unit of Orthopaedy and Traumatology, Hospital of Pavullo nel Frignano (MO), Italy
  • F. Sadile Department of Public Health, “Federico II” Naples University School of Medicine and Surgery, Trauma and Orthopaedic Unit, Naples, Italy
  • G. Fraschini University of Milan, Residency Program in Orthopaedics and Trauma Surgery, Milan, Italy
  • M. Fortina Department of Orthopaedics and Traumatology, University Hospital of Siena, Siena, Italy
  • A. Frizziero Department of Physical and Rehabilitation Medicine, University of Padova, Padova, Italy
  • N. Chiarelli Operative Unit of Orthopaedy and Traumatology, SS Annunziata Hospital of Cento (FE), Italy
  • V. Salini Department of Medicine and Science of Aging, University G. D’Annunzio, Chieti Scalo (CH), Italy
  • U. Tarantino Department of Orthopaedics and Traumatology, University of Rome “Tor Vergata”, Rome, Italy
  • N. Voglino Operative Unit of Orthopaedy and Traumatology, Hospital of Città di Castello, Città di Castello (PG), Italy
  • A. Castagna Center for Shoulder and Elbow Surgery, Humanitas Clinical and Research Center, Rozzano (MI), Italy
  • F. A. Grassi Department of Orthopedics and Traumatology, University of East Piedmont, Hospital “Maggiore della Carità”, Via Mazzini 18, Novara, Italy
  • S. Rovati IBSA Institut Biochimique SA, Pambio-Noranco, Switzerland
  • V. Frangione IBSA Institut Biochimique SA, Pambio-Noranco, Switzerland

stefano.bernasconi@ao-legnano.it

Keywords

betamethasone valerate, lateral elbow tendinopathy, pain relief, PRTEE

Abstract

Background. This placebo-controlled, double-blind study evaluated the short-term effects of betamethasone valerate (BMV) 2.25mg medicated plaster in patients with chronic lateral elbow tendinopathy (LET).

Methods. Adult outpatients with LET and on-movement pain intensity >50 mm at a 0-100mm visual analogue scale (VAS) were randomised to receive BMV (N=101) or placebo (N=98), 12 hours/day for 4 weeks. Pain decrease from baseline to Day 28 was the primary endpoint. Other endpoints were: patient-rated tennis elbow evaluation (PRTEE), use of rescue paracetamol, tolerability at the application site.

Results. Decrease in mean pain VAS from baseline to Day 28 was significantly higher with BMV vs. placebo: the difference between groups (intent-to-treat) was -8.57 mm (95% CI: -16.19 to-0.95 mm; p=0.028). Higher pain decreases in the BMV group over placebo were reported weekly during each control visit and daily in patients’ measurements on diaries. Treatment with BMV also led to higher decreases vs. placebo in PRTEE total, pain and functional disability score. Use of paracetamol was minimal. BMV plaster was well tolerated for general and local adverse events.

Conclusions. BMV 2.25mg plaster was superior to placebo and well tolerated in patients with painful chronic LET.

View the entire article

Downloads

Published

2019-12-31

How to Cite

1.
Bernasconi S, Causero A, Giaffreda G, Papalia R, Caruso G, Bonanno G, et al. Short-Term Efficacy and Safety of Betamethasone Valerate 2.25 mg Medicated Plaster in Patients with Chronic Lateral Epicondylitis: Results of a Randomised, Double Blind, Placebo-controlled Study. MLTJ [Internet]. 2019 Dec. 31 [cited 2026 Nov. 20];9(4). Available from: https://mltj.online/index.php/mltj/article/view/7136

Most read articles by the same author(s)